Spotify has confirmed that it paid €50 million (US$56 million) to acquire Parcast, the story-based podcasting studio it snapped up last month.
Founded in 2016, Los Angeles-based Parcast has two production studios, through which it has created more than a dozen popular podcast shows, including Serial Killers, Female Criminals, and Mind’s Eye.
Some estimates had pegged the Parcast purchase price at around US$100 million, though the confirmed value is notably less. But Parcast represented Spotify’s third podcast-related acquisition in less than two months, after the latter bought Gimlet Media and Anchor in February. An Securities and Exchange Commission filing at the time revealed that Spotify intended to pay around €300 million (US$335.5 million) for Gimlet and Anchor, although the music-streaming giant has now confirmed that the final figure is €308 million (US$344 million).
In all, Spotify has spent €358 million (US$400 million) to acquire three podcast startups in 2019 so far. In its Q4 shareholder letter back in February, the company stated it had earmarked up to US$500 million for similar deals throughout 2019, so we can perhaps expect more from Spotify on the acquisition front in the coming months.
Full Content: Venture Beat
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas